Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Prepaid Assets (2016 - 2025)

Guided Therapeutics' Prepaid Assets history spans 16 years, with the latest figure at $123000.0 for Q3 2025.

  • For Q3 2025, Prepaid Assets fell 41.71% year-over-year to $123000.0; the TTM value through Sep 2025 reached $123000.0, down 41.71%, while the annual FY2024 figure was $173000.0, 6.13% up from the prior year.
  • Prepaid Assets for Q3 2025 was $123000.0 at Guided Therapeutics, up from $23000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $453000.0 in Q1 2022 and bottomed at $23000.0 in Q2 2025.
  • The 5-year median for Prepaid Assets is $137000.0 (2022), against an average of $152315.8.
  • The largest annual shift saw Prepaid Assets skyrocketed 1061.54% in 2022 before it crashed 79.46% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $377000.0 in 2021, then plummeted by 63.66% to $137000.0 in 2022, then grew by 18.98% to $163000.0 in 2023, then grew by 6.13% to $173000.0 in 2024, then fell by 28.9% to $123000.0 in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Prepaid Assets are $123000.0 (Q3 2025), $23000.0 (Q2 2025), and $61000.0 (Q1 2025).